Petydyna i Prometazyna: interakcja
Petydyna i Prometazyna: obie etykiety FDA opisują to połączenie najsilniejszymi sformułowaniami, takimi jak przeciwwskazanie, ostrzeżenie w ramce lub zalecenie, aby go unikać.
Nie łączyć bez zaleceń lekarza przepisującego leki. Poniższe sformułowania z etykiety to najsilniejsze, jakich używa FDA.
Co mówią etykiety FDA
Źródło: etykieta leku Petydyna (DEMEROL) · obowiązuje od 2026-07-20
Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.
Reserve concomitant prescribing of DEMEROL Injection and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.3) , Drug Interactions (7) ] .
• Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.
Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Profound sedation, respiratory depression, coma, and death may result from the concomitant use of DEMEROL Injection with benzodiazepines and/or other CNS depressants, including alcohol (e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics,…
Advise both patients and caregivers about the risks of respiratory depression and sedation when DEMEROL Injection is used with benzodiazepines or other CNS depressants (including alcohol and illicit drugs).
Źródło: etykieta leku Prometazyna (PROMETHAZINE HYDROCHLORIDE) · obowiązuje od 2026-04-16
The impairment may be amplified by concomitant use of other central-nervous-system depressants such as alcohol, sedatives/hypnotics (including barbiturates), narcotics, narcotic analgesics, general anesthetics, tricyclic antidepressants, and tranquilizers; therefore such agents should either be eliminated or given in reduced dosage in the presence of promethazine…
It should be used with caution in persons with seizure disorders or in persons who are using concomitant medications, such as narcotics or local anesthetics, which may also affect seizure threshold.
Drug Interactions CNS Depressants Promethazine Syrup may increase, prolong, or intensify the sedative action of other central-nervous-system depressants, such as alcohol, sedatives/hypnotics (including barbiturates), narcotics, narcotic analgesics, general anesthetics, tricyclic antidepressants, and tranquilizers; therefore, such agents should be avoided or administered…
When given concomitantly with Promethazine Syrup, the dose of barbiturates should be reduced by at least one-half, and the dose of narcotics should be reduced by one-quarter to one-half.
CNS Depressants Promethazine Syrup may increase, prolong, or intensify the sedative action of other central-nervous-system depressants, such as alcohol, sedatives/hypnotics (including barbiturates), narcotics, narcotic analgesics, general anesthetics, tricyclic antidepressants, and tranquilizers; therefore, such agents should be avoided or administered in reduced…
Więcej leków niż te dwa? Interakcje się kumulują. Całą listę można sprawdzić jednocześnie; pozostaje ona w przeglądarce.
Otwórz w wyszukiwarceTo nie jest porada medyczna. Interaction Checker cytuje tekst etykiet FDA i karty informacyjne NIH. To, czy interakcja ma znaczenie w konkretnym przypadku, zależy od dawek, pory przyjmowania, czynności nerek i wątroby oraz innych schorzeń. Należy to potwierdzić u farmaceuty lub lekarza przepisującego leki.